SSRI Head-to-Head · Two of the Most-Prescribed Antidepressants

sertraline

Zoloft FDA: MDD · OCD · PTSD · PMDD · more

fluoxetine

Prozac FDA: MDD · OCD · Bulimia · Bipolar dep.

Zoloft vs Prozac: Which SSRI Is Right for You?

Q: Is Zoloft or Prozac better for anxiety?

Both treat anxiety, but they differ by indication. Zoloft (sertraline) holds FDA approvals for panic disorder, social anxiety disorder, PTSD, and PMDD — giving it a substantial advantage for those specific diagnoses. Prozac (fluoxetine) is FDA-approved for panic disorder but not for social anxiety, PTSD, or PMDD. For generalized anxiety, neither drug has an FDA approval (that goes to escitalopram and paroxetine), though both are used off-label. The best choice depends on your specific anxiety diagnosis and full clinical picture — discuss it with your prescriber.

Q: Which SSRI causes more weight gain?

Both Zoloft and Prozac are considered among the more weight-neutral SSRIs, especially compared to paroxetine. Prozac (fluoxetine) is actually associated with mild initial weight loss in some patients early in treatment — though this effect often does not persist long-term. With both drugs, modest weight gain is possible over months to years, as with all SSRIs. Neither is considered a significant weight-gain drug, and the difference between them in this regard is small. Individual factors — baseline weight, diet, activity level, and duration of treatment — matter more than which drug you are on.

Sertraline (Zoloft) and fluoxetine (Prozac) are two of the world's most-prescribed antidepressants. They share the same core mechanism but diverge sharply on one clinically critical dimension: half-life. Prozac's extraordinarily long half-life — and the weeks-long active metabolite norfluoxetine — fundamentally changes how it behaves when you miss a dose, switch medications, or stop treatment.

Same class, identical mechanism: Both drugs are SSRIs that block the serotonin transporter (SERT), preventing reuptake of serotonin from the synapse. Their core pharmacology is the same. The differences lie in half-life, approved indications, drug interactions, and activation profile.

The defining difference

Prozac's half-life is 1–4 days for the parent drug, with an active metabolite (norfluoxetine) that persists for 4–16 days. Zoloft's half-life is approximately 26 hours with no clinically significant active metabolite. This single pharmacokinetic difference drives Prozac's uniquely mild discontinuation profile, its forgiveness of missed doses, and its more complex drug interaction picture during switches.

Both: generic available Both: once-daily dosing Prozac: longest SSRI half-life Rx only

Side-by-side comparison

Zoloft vs Prozac at a Glance

Scroll horizontally on small screens. Both drugs require a prescription and should only be started or stopped under prescriber supervision.

Category	Zoloft (sertraline)	Prozac (fluoxetine)
Generic name	Sertraline	Fluoxetine
Drug class	SSRI	SSRI
Mechanism	SERT inhibition (serotonin reuptake)	SERT inhibition (serotonin reuptake)
FDA-approved uses	MDD OCD PTSD Panic disorder Social anxiety PMDD	MDD OCD Panic disorder Bulimia nervosa Bipolar depression (w/ olanzapine) Treatment-resistant depression (w/ olanzapine)
Half-life	~26 hours	1–4 days (parent) 4–16 days (norfluoxetine metabolite)
Available strengths	25mg, 50mg, 100mg tablets; oral concentrate	10mg, 20mg, 40mg, 60mg capsules/tablets; 90mg weekly capsule; oral liquid
Generic available	Yes — widely available, inexpensive	Yes — widely available, inexpensive
CYP2D6 inhibition	Moderate inhibitor — some interaction potential	Strong inhibitor — significant interactions with many CYP2D6-metabolized drugs
Discontinuation risk	Moderate — taper required	Very Low — self-tapering metabolite
Activation / sedation	Generally neutral	Activating — may cause insomnia or jitteriness, especially early
Weight effects	Relatively weight-neutral long-term	May cause mild initial weight loss; relatively neutral long-term
Pregnancy preference	Often preferred per many guidelines — larger human data record	Formally Category C; less preferred than sertraline in most guidelines
Pediatric approvals	OCD in children 6+	MDD in children 8+; OCD in children 7+
Missed dose tolerance	Moderate — levels drop more noticeably within 24 hours	Very high — metabolite maintains levels for days after a missed dose

Available strengths shown above; how strengths are selected and adjusted is determined by your prescriber based on your individual clinical situation.

Individual drug profiles

Each Drug in Depth

The biggest clinical difference

Why Prozac's Half-Life Changes Everything

Half-life is not just a pharmacokinetics footnote — for these two drugs, it drives real differences in how patients experience stopping, switching, and missing doses.

Zoloft (sertraline) — ~26-hour half-life

Stopping: Blood levels fall significantly within 24–48 hours of the last dose. Abrupt discontinuation commonly produces symptoms: dizziness, nausea, brain zaps, irritability, flu-like malaise. A gradual taper over weeks (or months, depending on duration of use) substantially reduces this risk.

Missed dose: A missed day will be noticeable for some patients — levels drop enough that mild discontinuation symptoms can appear before the next dose.

Switching: Because Zoloft clears the system within a few days, switching to a new antidepressant is relatively straightforward. The new drug's effects are not delayed by a long-lingering predecessor.

Prozac (fluoxetine) — 1–4 days + metabolite 4–16 days

Stopping: Even after the last dose, norfluoxetine maintains significant SERT inhibition for weeks — effectively acting as a natural, built-in taper. Discontinuation syndrome is rare, and some patients stop without any structured taper (under prescriber guidance). This is the single strongest practical advantage of fluoxetine over other SSRIs.

Missed dose: A missed day — or even a few days — has minimal clinical impact. Blood levels stay stable enough that most patients notice nothing.

Switching: The metabolite complicates switches. Prozac's CYP2D6 inhibition can elevate levels of the new medication for weeks after stopping, and serotonergic overlap must be managed carefully. Prescribers plan for a washout or conservative cross-taper.

Tolerability head-to-head

How Their Side Effect Profiles Compare

Both drugs share the same class-wide side effect profile. The differences are in degree and character — and individual variation is always substantial.

Zoloft (sertraline)

GI upset: Nausea and loose stools are among the most commonly reported complaints, particularly early in treatment. Usually improves within the first 2–4 weeks as the body adjusts.

Sexual side effects: Present and significant (class-wide effect). Similar overall rates to Prozac. Common reasons include decreased libido and delayed orgasm.

Activation / sedation: Generally neutral — most patients do not find it particularly activating or sedating, which makes it a versatile choice for daytime or evening use.

Weight: Relatively weight-neutral. Long-term modest weight gain is possible, as with all SSRIs, but is not a prominent feature of sertraline specifically.

Drug interactions: Moderate CYP2D6 inhibitor — worth reviewing with your pharmacist, but considerably less interaction burden than Prozac.

Prozac (fluoxetine)

GI upset: Nausea can occur, though some patients find GI side effects less pronounced than with Zoloft. Individual experiences vary.

Sexual side effects: Present and significant (class-wide effect). Similar overall rates to Zoloft.

Activation / sedation: Distinctly activating for many patients. Can improve fatigue and motivation, but may worsen anxiety or insomnia — particularly in the first weeks of treatment. Morning dosing is often preferred.

Weight: May cause mild initial weight loss in some patients — the only SSRI commonly associated with this. The effect typically does not persist long-term.

Drug interactions: Strong CYP2D6 inhibitor with a clinically significant interaction profile. Careful review with prescriber and pharmacist is important if taking other medications.

Important class-wide warning: Both Zoloft and Prozac carry an FDA black box warning about increased risk of suicidal thoughts in children, adolescents, and young adults (under 25), particularly in the first few weeks of treatment or after dose changes. Monitor for worsening mood or new thoughts of self-harm and report these to your prescriber immediately.

Drug interaction profile

CYP2D6 Inhibition: A Key Practical Difference

Both drugs inhibit the CYP2D6 enzyme, which metabolizes many common medications. The degree of inhibition — and how long it persists after stopping — differs meaningfully between them.

Zoloft — Moderate CYP2D6 inhibitor

Sertraline inhibits CYP2D6 to a moderate degree. This creates meaningful interaction potential with drugs metabolized by CYP2D6 — including certain antipsychotics, opioids, beta-blockers, and TCAs — but the effect is considerably less than Prozac's. After stopping Zoloft, inhibition resolves within a few days as the drug clears. This makes switching away from Zoloft to a CYP2D6-sensitive drug relatively clean and predictable.

Prozac — Strong CYP2D6 inhibitor

Fluoxetine is one of the most potent CYP2D6 inhibitors in clinical use. Its interaction profile is amplified by the fact that norfluoxetine — the active metabolite — also inhibits CYP2D6 and persists for weeks after the last dose. This means that even patients who have stopped Prozac can have significant drug interaction effects for a month or more. Prescribers and pharmacists must account for this when adding any CYP2D6-sensitive medication, even after stopping. Always tell every provider and pharmacist you are taking or recently took fluoxetine.

Clinical verdict

Which Is Right for Your Situation?

Neither drug is universally "better." The right choice depends on your diagnosis, other medications, pregnancy considerations, and how your body responds. These are the clearest evidence-based distinctions.

Choose Zoloft if…

You have PTSD or PMDD — Zoloft is FDA-approved for both; Prozac is not approved for either

You have social anxiety disorder — a Zoloft-only FDA approval among these two drugs

You are pregnant or planning a pregnancy — Zoloft has the largest human pregnancy data record and is most frequently cited as the preferred SSRI in pregnancy guidelines

You are on multiple other medications where Prozac's strong CYP2D6 inhibition would create problematic interactions

You prefer a neutral activation profile — neither activating nor sedating for most people

Choose Prozac if…

Stopping easily matters — Prozac's built-in slow taper makes discontinuation far gentler than any other SSRI, often without structured tapering

You are treating pediatric depression — Prozac is FDA-approved for MDD in children aged 8 and older; Zoloft's pediatric approval covers OCD only

You have bulimia nervosa — Prozac is the only SSRI with an FDA approval specifically for this condition

An activating effect is desirable — fatigue, low energy, and low motivation respond well to Prozac's stimulating profile

You have adherence challenges or irregular schedules — Prozac's long half-life is the most forgiving of occasional missed doses

Frequently asked questions

Common Questions

Is Zoloft or Prozac better for anxiety?

Both treat anxiety, but they differ meaningfully by specific diagnosis. Zoloft (sertraline) holds FDA approvals for panic disorder, social anxiety disorder, PTSD, and PMDD — giving it a substantial advantage for those specific diagnoses. Prozac (fluoxetine) is FDA-approved for panic disorder but not for social anxiety, PTSD, or PMDD. For generalized anxiety disorder (GAD), neither drug has an FDA approval — that distinction belongs to escitalopram and paroxetine — though both Zoloft and Prozac are used off-label for GAD by many prescribers. The best choice depends on your specific anxiety diagnosis and your full clinical picture. Your prescriber should help match the right indication to the right drug.

Which is easier to stop taking, Zoloft or Prozac?

Prozac (fluoxetine) is substantially easier to stop than Zoloft (sertraline) — and this is its most widely cited practical advantage. Fluoxetine's active metabolite norfluoxetine has a half-life of 4–16 days, effectively providing a built-in, slow self-taper after the last dose. Discontinuation syndrome is rare with Prozac; some patients stop without any structured taper at all (though this should still be discussed with a prescriber). Zoloft has a half-life of roughly 26 hours with no significant active metabolite, so levels fall quickly after stopping. Discontinuation syndrome — dizziness, nausea, brain zaps, flu-like malaise — is common when Zoloft is stopped too quickly. A gradual taper over weeks is the standard recommendation. If anticipating a future stop is a priority for you, this factor meaningfully favors Prozac.

Which SSRI causes more weight gain?

Neither Zoloft nor Prozac is considered a significant weight-gain medication — both are among the more weight-neutral SSRIs, especially compared to paroxetine. Prozac (fluoxetine) is actually associated with mild initial weight loss in some patients early in treatment, though this typically does not persist over months to years. Zoloft is generally considered slightly more weight-neutral over the long term, though the difference between the two is modest in most patients. Individual factors — baseline metabolism, diet, activity level, duration of treatment, and whether the underlying depression itself was affecting appetite — have a larger influence on weight changes than which of these two drugs you are taking. If significant weight change occurs on either medication, discuss it with your prescriber rather than stopping without guidance.

Can you switch from Prozac to Zoloft?

Yes, but the switch from Prozac to Zoloft requires more planning than most SSRI-to-SSRI transitions. Fluoxetine's very long half-life — especially the norfluoxetine metabolite's 4–16 day half-life — means it continues affecting the body for weeks after the last dose. This creates two complicating factors: first, serotonergic overlap between fluoxetine's lingering levels and starting sertraline must be managed to minimize the risk of excessive serotonin activity; second, Prozac's strong CYP2D6 inhibition can temporarily elevate sertraline levels as enzyme activity slowly recovers over weeks after stopping fluoxetine. Prescribers typically plan for a washout period or a conservative, gradual cross-taper to account for this. The reverse direction — switching from Zoloft to Prozac — is generally simpler because sertraline clears quickly. Either switch should be managed by your prescriber; never adjust or stop SSRIs independently.

Which is better for OCD, Zoloft or Prozac?

Both Zoloft (sertraline) and Prozac (fluoxetine) carry FDA approval for OCD in adults, and head-to-head OCD trials do not consistently favor one over the other for efficacy. For children and adolescents with OCD specifically, sertraline has an FDA approval for OCD in children as young as 6, while fluoxetine is approved for OCD in children aged 7 and older — giving Zoloft a slight edge for the youngest pediatric patients. Fluoxetine's broader pediatric approvals (including MDD in children 8+) make it a common choice when a prescriber wants to treat both depression and OCD in a child with a single medication. In adults, prescribers often factor in practical considerations: Prozac's easier discontinuation profile is useful if OCD treatment is planned to eventually conclude; Zoloft's broader anxiety approvals are useful if comorbid social anxiety or PTSD are also present. Both are reasonable, guideline-supported first-line choices for OCD.

Medical disclaimer

Important notice

This page is designed for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Sertraline and fluoxetine are prescription medications and should only be started, stopped, or adjusted under the supervision of a qualified prescriber who knows your complete medical history. Individual responses to medications vary significantly and cannot be predicted from population-level data alone. If you are experiencing a mental health emergency, call 988 (Suicide and Crisis Lifeline) or 911. For non-emergency questions about your medications, contact your prescriber or pharmacist directly. Poison Control: 1-800-222-1222.